Day: April 24, 2024

CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to report its financial and operating results for the three months ended March 31, 2024. The unaudited condensed consolidated interim financial statements, accompanying notes and MD&A are being filed on SEDAR (www.sedar.com) and will be available on Pulse’s website at www.pulseseismic.com. Pulse’s Board of Directors today approved a 9% increase to the regular dividend and declared a regular quarterly dividend of $0.015 per share. This increase results in an annualized regular dividend of $0.06 per share. The total of the dividend will be approximately $780,000 based on Pulse’s 51,994,563 common  shares outstanding as of April 24, 2024, and will be paid on May 23, 2024, to shareholders of record...

NOTABLE ITEMS FOR THE QUARTER INCLUDE:DILUTED EARNINGS PER SHARE WERE $0.15 FOR THE CURRENT QUARTER COMPARED TO $0.19 FOR THE TRAILING QUARTER, AND $0.26 FOR THE FIRST QUARTER OF 2023. NET INTEREST INCOME OF $27.9 MILLION, DECREASED $1.0 MILLION, OR 3.6%, PRIMARILY REFLECTING INCREASED FUNDING COSTS AND LOWER LOAN BALANCES. AVERAGE YIELDS ON INTEREST-EARNING ASSETS INCREASED 17 BASIS POINTS TO 4.27%, WHILE THE AVERAGE COST OF INTEREST-BEARING LIABILITIES INCREASED 37 BASIS POINTS TO 2.89% FOR THE CURRENT QUARTER COMPARED TO THE TRAILING QUARTER. NET INTEREST MARGIN DECREASED TO 2.03%, OR 14 BASIS POINTS, FOR THE CURRENT QUARTER COMPARED TO THE TRAILING QUARTER. TOTAL DEPOSITS (EXCLUDING BROKERED) INCREASED BY APPROXIMATELY $44 MILLION, OR 4.7% ANNUALIZED, DRIVEN BY INCREASES IN CERTIFICATES OF DEPOSITS AND TRANSACTION ACCOUNTS. COST...

RUSTON, La., April 24, 2024 (GLOBE NEWSWIRE) — Century Next Financial Corporation (the “Company”) (OTCQX: CTUY), the holding company of Century Next Bank, with $793.8 million in assets, today announced financial results for the 1st quarter ended March 31, 2024. Financial Performance For the three months ended March 31, 2024, the Company had net income after tax of $2.66 million compared to net income of $1.06 million for the three months ended March 31, 2023, an increase of $1.6 million or 151%. Earnings per share (EPS) for the three months ended March 31, 2024 were $1.48 per basic and diluted share compared to $0.59 per basic and diluted share reported for the three months ended March 31, 2023. Balance Sheet Overall, total assets increased by $27.9 million or 3.6% to $793.8 million at March 31, 2024 compared to $765.9 million...

— Recorded Third Quarter Revenue of $33.8 Million — — Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million — — Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 2024 — — Completed Convertible Debt Offering Subsequent to Quarter End, Extending Debt Maturity to 2029 — TUSTIN, Calif., April 24, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the third quarter and nine months ended January 31, 2024. Highlights...

Q1 2024 revenue and non-IFRS adjusted EPS* above the high end of guidance ranges;2024 full-year outlook raised (All amounts in U.S. dollars. Per share information based on diluted shares outstanding unless otherwise noted.) TORONTO, April 24, 2024 (GLOBE NEWSWIRE) — Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced financial results for the quarter ended March 31, 2024 (Q1 2024)†. “We are pleased with our strong start to the year, delivering revenue growth of 20% in Q1 2024 compared to the prior-year period, and continued non-IFRS operating margin* expansion. Our solid performance was reflected in revenue and non-IFRS adjusted EPS* each in excess of the high end of our guidance ranges,” said Rob...